Franklin Resources’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.1M | Buy |
2,359,677
+298,272
| +14% | +$2.79M | 0.01% | 897 |
|
|
2025
Q1 | $25.3M | Buy |
2,061,405
+294,546
| +17% | +$3.62M | 0.01% | 830 |
|
|
2024
Q4 | $23.4M | Buy |
1,766,859
+3,582
| +0.2% | +$47.4K | 0.01% | 852 |
|
|
2024
Q3 | $34.9M | Buy |
1,763,277
+208,043
| +13% | +$4.12M | 0.01% | 709 |
|
|
2024
Q2 | $31.9M | Buy |
1,555,234
+59,529
| +4% | +$1.22M | 0.01% | 703 |
|
|
2024
Q1 | $35.6M | Buy |
1,495,705
+142,800
| +11% | +$3.4M | 0.01% | 685 |
|
|
2023
Q4 | $29.2M | Buy |
+1,352,905
| New | +$29.2M | 0.01% | 657 |
|